We are live on ! Find out more
HPG

Harvest Portfolios Group Portfolio holdings

AUM $6.06B
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+16.63%
3 Year Est. Return
+50.33%
5 Year Est. Return
10 Year Est. Return
AUM
$2.36B
AUM Growth
+$240M
Cap. Flow
+$24.3M
Cap. Flow %
1.03%
Top 10 Hldgs %
25.91%
Holding
225
New
7
Increased
65
Reduced
144
Closed
7

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$17.9M
2
KEYS icon
Keysight
KEYS
+$16.2M
3
FTNT icon
Fortinet
FTNT
+$15.4M
4
AMGN icon
Amgen
AMGN
+$9.4M
5
UNH icon
UnitedHealth
UNH
+$8.46M

Sector Composition

Rank Sector Weight
1 Healthcare 47.28%
2 Technology 19.6%
3 Financials 7.01%
4 Consumer Discretionary 5.24%
5 Communication Services 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLT icon
1
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
$78M 3.31%
788,623
+734,038
+1,345% +$66.3M
JNJ icon
2
Johnson & Johnson
JNJ
$625B
$70.1M 2.98%
447,539
+13,348
+3% +$2.05M
UNH icon
3
UnitedHealth
UNH
$370B
$66.7M 2.83%
126,722
-15,865
-11% -$8.46M
TMO icon
4
Thermo Fisher Scientific
TMO
$220B
$57.2M 2.43%
107,797
+10,098
+10% +$4.89M
A icon
5
Agilent Technologies
A
$41.2B
$57M 2.42%
409,860
-17,078
-4% -$2.03M
ABT icon
6
Abbott
ABT
$187B
$56.9M 2.41%
516,993
+10,952
+2% +$1.09M
DHR icon
7
Danaher
DHR
$144B
$56.8M 2.41%
245,730
+14,624
+6% +$3.11M
BSX icon
8
Boston Scientific
BSX
$71.5B
$56.4M 2.39%
976,110
-38,639
-4% -$2.06M
MDT icon
9
Medtronic
MDT
$112B
$56.2M 2.38%
681,978
+53,322
+8% +$4.06M
MRK icon
10
Merck
MRK
$318B
$55.6M 2.36%
509,926
-4,225
-0.8% -$439K
ABBV icon
11
AbbVie
ABBV
$435B
$54.6M 2.31%
352,099
-14,149
-4% -$2.06M
LLY icon
12
Eli Lilly
LLY
$1.06T
$54.4M 2.31%
93,356
-2,600
-3% -$1.52M
REGN icon
13
Regeneron Pharmaceuticals
REGN
$80.8B
$53.6M 2.27%
61,001
-3,601
-6% -$2.97M
ZTS icon
14
Zoetis
ZTS
$30B
$53.4M 2.26%
270,565
-23,316
-8% -$4.13M
AMGN icon
15
Amgen
AMGN
$222B
$53.3M 2.26%
185,045
-34,511
-16% -$9.4M
NVS icon
16
Novartis
NVS
$297B
$52.6M 2.23%
521,332
+3,715
+0.7% +$359K
AZN icon
17
AstraZeneca
AZN
$250B
$52.2M 2.21%
387,373
-9,644
-2% -$1.25M
ISRG icon
18
Intuitive Surgical
ISRG
$134B
$51.6M 2.19%
152,962
-22,302
-13% -$6.65M
BMY icon
19
Bristol-Myers Squibb
BMY
$132B
$51.6M 2.19%
1,005,155
+95,718
+11% +$5.02M
SYK icon
20
Stryker
SYK
$130B
$50.7M 2.15%
169,169
-17,617
-9% -$4.94M
ELV icon
21
Elevance Health
ELV
$85.5B
$50.2M 2.13%
106,483
-8,234
-7% -$3.81M
TXN icon
22
Texas Instruments
TXN
$261B
$40.1M 1.7%
235,275
+19,386
+9% +$3M
ACN icon
23
Accenture
ACN
$108B
$38M 1.61%
108,409
-14,182
-12% -$4.57M
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$4.33T
$38M 1.61%
272,232
-9,847
-3% -$1.32M
MSFT icon
25
Microsoft
MSFT
$3.71T
$35.7M 1.51%
94,960
-21,399
-18% -$7.62M

Similar funds

Harvest Portfolios Group's Q4 2023 Portfolio in Review

As of Q4 2023, Harvest Portfolios Group held 225 positions worth $2.36B, up 11% from $2.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Harvest Portfolios Group's Q4 2023 filing shows 7 new, 65 increased, 144 reduced and 7 closed positions. Its largest new stake was Synopsys: 37,966 shares worth $19.5M. The largest sale was Citigroup, an estimated $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 51% a quarter earlier, followed by Technology and Financials.

  • Harvest Portfolios Group's largest Q4 2023 buy was Synopsys: 37,966 shares worth $19.5M.
  • Harvest Portfolios Group added most to iShares 20+ Year Treasury Bond ETF in Q4 2023, an estimated $66.3M increase.
  • Harvest Portfolios Group's biggest Q4 2023 reduction was Citigroup, cutting an estimated $17.9M.
  • Harvest Portfolios Group fully exited Keysight in Q4 2023, selling an estimated $16.2M.
  • Harvest Portfolios Group's ten largest holdings make up 26% of its $2.36B portfolio in Q4 2023.
  • Harvest Portfolios Group opened 7 new positions and closed 7 in Q4 2023.
  • Harvest Portfolios Group's portfolio value rose 11% quarter-over-quarter to $2.36B.

Based on Harvest Portfolios Group's 13F filing for Q4 2023, filed 14 Feb 2024.